“A multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of non-healing diabetic foot and venous leg ulcers (STABLECAMP)”, ijtr, vol. 1, no. 1, Nov. 2025, doi: 10.63676/3csvta73.